泮托拉唑钠联合前列地尔治疗重症急性胰腺炎患者的临床效果

doi:10.3760/cma.j.issn.1007-1245.2023.16.019

国际医药卫生导报 ›› 2023, Vol. 29 ›› Issue (16): 2302-2305.DOI: 10.3760/cma.j.issn.1007-1245.2023.16.019

泮托拉唑钠联合前列地尔治疗重症急性胰腺炎患者的临床效果

聂慧超

新蔡县人民医院检验科，驻马店　463599

收稿日期:2023-05-18 出版日期:2023-08-15 发布日期:2023-08-29
通讯作者: Email: 15093537720@163.com

Clinical effect of pantoprazole sodium combined with alprostadil in treatment of patients with severe acute pancreatitis

Nie Huichao

Department of Clinical Laboratory, Xincai County People's Hospital, Zhumadian 463599, China

Received:2023-05-18 Online:2023-08-15 Published:2023-08-29
Contact: Email:15093537720@163.com

摘要/Abstract

摘要：

目的　探讨泮托拉唑钠联合前列地尔治疗重症急性胰腺炎（SAP）患者的临床效果及对血清丙氨酸氨基转移酶（ALT）、淀粉酶（AMY）及肌酐（Cr）水平的影响。方法　选取2019年6月至2020年1月在新蔡县人民医院确诊并治疗的74例SAP患者，遵照随机分组标准分为对照组和研究组，每组37例。对照组中，男25例、女12例，年龄（47.5±2.1）岁，应用泮托拉唑钠治疗；研究组中，男24例、女13例，年龄（47.1±2.2）岁，应用泮托拉唑钠联合前列地尔治疗。观察比较两组恢复胃肠功能的相关指标水平差异；比较两组患者治疗前后的血清ALT、AMY及Cr水平，治疗后不同时间点的急性生理学和慢性健康评价（APACHE-Ⅱ）评分差异。采用t检验、χ²检验进行统计分析。结果　研究组临床治疗有效率为81.08%（30/37），对照组为54.05%（20/37），两组比较差异有统计学意义（P<0.05）。研究组恢复胃肠功能的相关指标水平时间均短于对照组（均P<0.05）。研究组治疗后的血清ALT、AMY及Cr水平均显著低于对照组（均P<0.05）。研究组治疗后不同时间点的APACHE-Ⅱ评分均显著低于对照组（均P<0.05）。研究组不良反应发生率小于对照组，但差异无统计学意义（P>0.05）。结论　SAP患者联合使用泮托拉唑钠及前列地尔治疗可显著缩短恢复胃肠功能的时间，降低AMY、ALT、Cr水平及APACHE-Ⅱ评分，临床效果显著，且不良反应率低，值得推广。

关键词:

重症急性胰腺炎, 泮托拉唑钠, 前列地尔, 临床效果

Abstract:

Objective　To investigate the clinical effect of pantoprazole sodium combined with alprostadil for patients with severe acute pancreatitis (SAP) and its influence on levels of amylase (AMY), alanine aminotransferase (ALT), and creatinine (Cr). Methods　Seventy-four patients with SAP diagnosed and treated in Xincai County People's Hospital from June 2019 to January 2020 were selected and divided into a control group and a study group according to the standard of randomization, with 37 patients in each group. There were 25 males and 12 females in the control group; they were (47.5±2.1) years old. There were 24 males and 13 females in the observation group; they were (47.1±2.2) years old. The control group were treated with pantoprazole sodium, and the study group with pantoprazole sodium and alprostadil. The levels of relevant indicators for restoring gastrointestinal function were compared between the two groups. The serum levels of ALT, AMY, and Cr before and after the treatment were compared between the two groups. The scores of acute physiology and chronic health evaluation (APACHE-Ⅱ) at different time points after the treatment were compared between the two groups. t and χ² were applied. Results　The clinical treatment efficacy of the study group was higher than that of the control group [81.08% (30/37) vs. 54.05% (20/37)], with a statistical difference between the two groups (P<0.05). The recovery times of relevant indicators of gastrointestinal function in the study group were shorter than those in the control group (all P<0.05). The serum levels of ALT, AMY, and Cr in the study group were significantly lower than those in the control group (all P<0.05). The APACHE-Ⅱ scores at different time points after the treatment in the study group were significantly lower than those in the control group (all P<0.05). The incidence of adverse reactions in the study group was lower than that in the control group, but with no statistical difference (P>0.05). Conclusions　The combination of pantoprazole sodium and alprostadil for patients with SAP can significantly shorten the time for them to recover gastrointestinal function, and reduce their levels of AMY, ALT, and Cr and the APACHE-Ⅱ score. The clinical effect is significant, and the adverse reaction rate is lower. Therefore, it is worth being generalized.

Key words:

Severe acute pancreatitis, Pantoprazole sodium, Alprostadil, Clinical effect

聂慧超.

泮托拉唑钠联合前列地尔治疗重症急性胰腺炎患者的临床效果 [J]. 国际医药卫生导报, 2023, 29(16): 2302-2305.

Nie Huichao.

Clinical effect of pantoprazole sodium combined with alprostadil in treatment of patients with severe acute pancreatitis [J]. International Medicine and Health Guidance News, 2023, 29(16): 2302-2305.

参考文献

[1] 李备,曾丽欢,黄潮英.泮托拉唑钠联合生长抑素对重症急性胰腺炎患者炎性反应及血液流变学的影响[J].现代消化及介入诊疗,2019,24(3):306-308,322.DOI:10.3969/j.issn.1672-2159.2019.03.025.
[2] 信然然,霍丽丽,刘岩.前列地尔联合血必净治疗急性重症胰腺炎的疗效及对血清肿瘤坏死因子-α白细胞介素-6降钙素原的影响[J].山西医药杂志,2020,49(2):137-140.DOI:10.3969/j.issn.0253-9926.2020.02.005.
[3] Wang YJ, He NH, Wang ZW, et al. Assessment of the combined effect of plasma exchange and plasma perfusion on patients with severe hepatitis awaiting orthotopic liver transplantation[J]. Int J Artif Organs, 2004,27(1):40-44. DOI: 10.1177/039139880402700109.
[4] 向相.生长抑素与泮托拉唑钠治疗重症急性胰腺炎的疗效观察[J].湖南中医药大学学报,2018,2(A01):949-950.
[5] Liu J, Jing P, Gao F, et al. Observation on the clinical effect and survival period of patients with esophageal cancer treated with UMIPIC combined with low dose radiotherapy[J]. J Clin Oncol, 2020, 38(15_suppl):e16517-e16517.
[6] 袁小兵,刘小莉,陈慰慰.通下活血汤联合泮托拉唑钠对急性胰腺炎患者血清降钙素原、血液黏度、免疫功能及血小板活化因子的影响[J].现代中西医结合杂志,2018,27(30):3359-3362.DOI:10.3969/j.issn.1008-8849. 2018.30.016.
[7] 柯秋晴,林志辉,卢世云.依诺肝素钠治疗重症急性胰腺炎的临床研究[J].药物评价研究,2020,43(5):901-906.DOI:10.7501/j.issn.1674-6376.2020.05.019.
[8] Yuan M, Zhu Z, Mao W, et al. Anlotinib combined with anti-PD-1 antibodies therapy in patients with advanced refractory solid tumors: a single-center, observational, prospective study[J]. Front Oncol, 2021,11:683502. DOI: 10.3389/fonc.2021.683502.
[9] 马翠梅,刘晗,张帆.泮托拉唑钠联合奥曲肽治疗对急性胰腺炎患者的有效性及不良反应发生的影响[J].国际医药卫生导报,2020,26(12):1770-1773.DOI:10.3760/cma.j.issn.1007-1245.2020.12.037.
[10] 韩坤.前列地尔治疗重症急性胰腺炎的临床效果及对肠道黏膜屏障功能和胃肠动力的影响[J].中国医药,2018,13(9):1365-1368.DOI:10.3760/j.issn.1673-4777.2018.09.021.
[11] Alfadhel M, Kerr A, Lee M,et al.TCT-420 the effect of body mass index on clinical outcomes in patients with acute coronary syndrome[J]. J Am Coll Cardiol, 2018, 72(13):B169-B170.DOI:10.1016/j.jacc.2018.08.1583.
[12] 尹霞,吴继雄,高德鸿,等.泮托拉唑钠注射剂联合氯吡格雷治疗急性心肌梗死伴消化道出血的临床研究[J].现代消化及介入诊疗,2018,23(3):316-319.DOI:10.3969/j.issn.1672-2159.2018.03.015.

泮托拉唑钠联合前列地尔治疗重症急性胰腺炎患者的临床效果

Clinical effect of pantoprazole sodium combined with alprostadil in treatment of patients with severe acute pancreatitis

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 6

编辑推荐

Metrics

[1]	周媚谭桂云莫颖茵薛亮. 基于中医"治未病"理论的母婴安康指导中心在妇产科临床应用的效果 [J]. 国际医药卫生导报, 2023, 29(5): 660-662.
[2]	王瑞瑞邱冬侠崔二平马淑焕. 全面护理模式对输入性疟疾患者的效果 [J]. 国际医药卫生导报, 2023, 29(4): 518-522.
[3]	韩章琴, 王同生. 不同剂量左氧氟沙星治疗利福平耐药肺结核的临床效果[J]. 国际医药卫生导报, 2022, 28(6): 762-765.
[4]	单醒瑜赖舒婷. 神阙隔药灸对阳虚质人群的干预效果观察[J]. 国际医药卫生导报, 2022, 28(16): 2343-2346.
[5]	刘志辉　闫彩霞　陈苑红. 加味桂芍四妙汤联合中药外洗治疗复发性外阴阴道假丝酵母菌病的临床效果[J]. 国际医药卫生导报, 2022, 28(13): 1876-1879.
[6]	吕文伟, 魏澎涛, 张寒, 康延杰, 杨凌博, 刘红燕, 尚亚峰, 孙建涛. 负压组合式输尿管镜与输尿管软镜钬激光碎石术治疗单侧上尿路结石的对比研究[J]. 国际医药卫生导报, 2021, 27(6): 871-874.